Zensita -D 50/5MG Tab

Composition

Dapagliflozin (5mg) + Sitagliptin (50mg)

Uses of Zensita -D 50/5MG Tab

Type 2 diabetes mellitus (as an add-on to diet and exercise) to improve glycaemic control in adults when dual therapy is appropriate.

• •Lowers fasting and post-meal blood glucose
• •Helps reduce HbA1c
• •Low risk of hypoglycaemia when used without insulin/sulfonylurea
• •May aid modest weight reduction
• •Once-daily convenient therapy

How it works

Sitagliptin is a DPP-4 inhibitor that increases incretin hormones, thereby increasing insulin release and decreasing glucagon levels in a glucose-dependent manner. Dapagliflozin is an SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion through the kidneys.

Directions for use

Tablet for oral use. Take as prescribed by the doctor, usually once daily; may be taken with or without food, preferably at the same time each day. Maintain adequate hydration; follow diet/exercise advice and monitor blood glucose.

Side effects

Common side effects of Zensita -D 50/5MG Tab may include:

• •Genital fungal infection
• •urinary tract infection
• •increased urination
• •thirst
• •